אמביזום

Country: Iżrael

Lingwa: Ebrajk

Sors: Ministry of Health

Ingredjent attiv:

AMPHOTERICIN B

Disponibbli minn:

GILEAD SCIENCES ISRAEL LTD

Kodiċi ATC:

J02AA01

Għamla farmaċewtika:

אבקה להכנת תרכיז לאינפוזיה

Kompożizzjoni:

AMPHOTERICIN B 50 MG/VIAL

Rotta amministrattiva:

תוך-ורידי

Tip ta 'preskrizzjoni:

מרשם נדרש

Manifatturat minn:

GILEAD SCIENCES IRELAND UC, IRELAND

Grupp terapewtiku:

AMPHOTERICIN B

Żona terapewtika:

AMPHOTERICIN B

Indikazzjonijiet terapewtiċi:

Antifungal antibiotic for the treatment of severe systemic and/or deep mycoses where toxicity precludes the use of conventional systemic amphotericin B in effective dosages. This drug should not be used to treat the common clinically inapparent forms of fungal disease which show only positive skin or serologic tests. Ambisome is also indicated for the treatment of systemic fungal infections in immunocompromised patients (e.g. patients with AIDS or cancer). Ambisome is also indicated for the primary therapy of visceral leishmaniasis in immunocompetent patients and immunocompromised patients (e.g. HIV positive). Empirical treatment of presumed fungal infection in febrile neutropenic patients.

Data ta 'l-awtorizzazzjoni:

2015-02-28